MONICA SCHEPP: Open Payments
NPI 1134672967 · MESQUITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 48 payments from 11 companies in 2025. Trend: 2023 $219 · 2024 $409 · 2025 $738
Food & beverage: $643Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $308 |
| UCB, Inc. | 9 | $135 |
| ABBVIE INC. | 3 | $65 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $55 |
| LEO Pharma Inc. | 2 | $39 |
| Amgen Inc. | 2 | $31 |
| GENZYME CORPORATION | 1 | $25 |
| Cipher Pharmaceuticals US LLC | 1 | $22 |
| Organon LLC | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
Products named: TREMFYA, Bimzelx, SKYRIZI, OTEZLA, ANZUPGO, DUPIXENT, Natroba, HADLIMA.
Industry payments across TX — which companies pay providers there.
